A Model for Dissecting Cancer Progression

News   Feb 20, 2017 | Original story from Mount Sinai Hospital

 
A Model for Dissecting Cancer Progression

Photomicrograph of acute lymphoblastic leukemia cells. (Wellcome Images)

 
 
 

RELATED ARTICLES

Uptake of Controlled Release Drug Delivery Technology Set to Increase?

News

The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.

READ MORE

New Automated Screening Method for Identifying Drug Candidates

News

Scientists at DESY have developed a new method that enables automated and fast screening of promising drug candidates.

READ MORE

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE